Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis
Press Releases
April 1, 2025

Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis

- Topline results expected by end of Q2 2025 –

bradford

The Bradford Era

Local & Social